SCHEMBL5847405

SCHEMBL5847405

COc1ccc(C2(O)CCN(CCCCn3cc(Cl)cn3)CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
LMNA P02545 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
CCR1 P32246 4/20 0.55
SLC6A1 P30531 1/20 0.53
SLC6A12 P48065 1/20 0.53
SLC6A11 P48066 1/20 0.53
DRD2 P14416 4/20 0.50
HTR1A P08908 3/20 0.50
DRD1 P21728 3/20 0.50
DRD5 P21918 3/20 0.50
SLC6A2 P23975 3/20 0.50
HTR2A P28223 3/20 0.50
SLC6A4 P31645 3/20 0.50
HTR7 P34969 3/20 0.50
HRH1 P35367 3/20 0.50
DRD3 P35462 3/20 0.50
HTR2B P41595 3/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5848812 0.89 CCR3 (0.59) LMNACCR1DRD2HTR1ADRD1
SCHEMBL5847342 0.88 CCR1 (0.53) CCR1DRD2HTR1ADRD1DRD5
SCHEMBL5848148 0.85 CCR3 (0.58) CCR1DRD2OPRM1CCR3POLB
SCHEMBL27508734 0.85 POLB (0.46) ALDH1A1LMNAMEN1KMT2ACCR1
SCHEMBL6160929 0.82 CCR1 (0.52) KMT2ACCR1DRD2HTR1ADRD1
SCHEMBL8416326 0.80 HSD17B10 (0.57) LMNAMEN1KMT2ADRD2HTR1A
SCHEMBL5847140 0.75 OPRL1 (0.56) LMNACCR1DRD2HTR1ADRD1
SCHEMBL11791855 0.75 CCR1 (0.76) ALDH1A1LMNAMEN1KMT2ACCR1
SCHEMBL11793314 0.74 DRD2 (0.83) MEN1KMT2ADRD2HTR1ADRD1
SCHEMBL5847004 0.74 CCR3 (0.58) CCR1DRD2HTR1AHTR2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39113-E1 Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-05-30 US claimed
EP-0991638-B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-08-17 EP claimed
EP-0721455-B9 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2005-04-20 EP claimed
EP-1175419-B1 ARYL SULFONYLS AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-05-28 EP claimed
EP-1097698-B1 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN ESTEVE LABOR DR (ES) 2003-05-07 EP claimed
EP-0721455-B1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2002-12-11 EP claimed
EP-1097698-A2 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-05-09 EP claimed